Acrivon TherapeuticsACRV
13F holders, Q4 2025 (December 31)At the end of Q4 2025, 48 institutions reported holding Acrivon Therapeutics Inc. (ACRV) in their 13F filings, unchanged from Q3 2025. 8 opened new positions and 8 sold out. The largest holders were Ra Capital Management, L.P. ($20.1M), Sands Capital Alternatives, LLC ($5.1M) and Citadel Advisors ($4.0M). 4 famous investors held it, including Ken Griffin (0.0% of Citadel Advisors's portfolio), Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Acrivon Therapeutics Inc.
- CUSIP
- 004890109
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $330K |
| Exits | 8 | $1.2M |
All 13F filers, Q3 2025 → Q4 2025: 1,843,357 shares bought and 755,810 shares sold, net +1,087,547 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 48 holders
| Ra Capital Management, L.P. | 0.21% | No change | 8,340,508 | $20.1M |
| Sands Capital Alternatives, LLC | 0.99% | No change | 2,122,605 | $5.1M |
| Citadel Advisors | 0.00% | Add +6.5% | 1,641,884 | $4.0M |
| Wellington Management Group LLP | 0.00% | No change | 888,130 | $2.1M |
| Vanguard Group Inc. | 0.00% | Add +11.6% | 698,857 | $1.7M |
| Renaissance Technologies | 0.00% | Add +1.7% | 634,169 | $1.5M |
| Two Sigma Investments, LP | 0.00% | Add +83.3% | 585,069 | $1.4M |
| Acadian Asset Management LLC | 0.00% | Add +531.7% | 581,208 | $1.4M |
| Marshall Wace, LLP | 0.00% | Add +231.3% | 496,081 | $1.2M |
| Acorn Capital Advisors, LLC | 0.33% | No change | 405,237 | $977K |
| UBS Group AG | 0.00% | Reduce -49.0% | 348,541 | $840K |
| Jane Street Group, LLC | 0.00% | Add +18.3% | 342,071 | $824K |
| Two Sigma Advisers, LP | 0.00% | Add +144.5% | 333,773 | $804K |
| BlackRock, Inc. | 0.00% | Reduce -38.0% | 205,124 | $494K |
| Geode Capital Management, LLC | 0.00% | Add +3.2% | 198,223 | $478K |
| Millennium Management | 0.00% | Reduce -34.4% | 121,524 | $293K |
| Goldman Sachs Group Inc. | 0.00% | Add +504.9% | 119,422 | $288K |
| State Street Corp. | 0.00% | No change | 67,145 | $162K |
| Northern Trust Corp. | 0.00% | Add +51.1% | 63,718 | $154K |
| Prelude Capital Management, LLC | 0.01% | New | 48,015 | $116K |
| Morgan Stanley | 0.00% | Reduce -18.1% | 46,831 | $113K |
| Bridgeway Capital Management, LLC | 0.00% | Add +87.3% | 42,900 | $103K |
| Squarepoint Ops LLC | 0.00% | Reduce -74.9% | 26,162 | $63K |
| Barclays PLC | 0.00% | Add +22.2% | 24,402 | $59K |
| Baker Bros. Advisors LP | 0.00% | No change | 22,809 | $55K |
| Quadrature Capital Ltd | 0.00% | New | 20,730 | $50K |
| XTX Topco Ltd | 0.00% | Reduce -42.8% | 20,572 | $50K |
| Dimensional Fund Advisors LP | 0.00% | Reduce -6.2% | 18,364 | $44K |
| Vermillion & White Wealth Management Group, LLC | 0.02% | New | 18,100 | $44K |
| Bank of America Corp. | 0.00% | Reduce -7.7% | 17,447 | $42K |
| JPMorgan Chase & Co. | 0.00% | Add +868.6% | 16,864 | $41K |
| Schonfeld Strategic Advisors LLC | 0.00% | New | 16,428 | $40K |
| Citigroup Inc. | 0.00% | Reduce -10.5% | 14,592 | $35K |
| Susquehanna International Group, LLP | 0.00% | New | 12,433 | $30K |
| Point72 Asset Management | 0.00% | New | 10,876 | $26K |
| AAF Wealth Management, LLC | 0.01% | No change | 10,678 | $26K |
| Marex Group Ltd | 0.00% | New | 10,000 | $24K |
| FMR LLC | 0.00% | No change | 8,622 | $21K |
| Federated Hermes, Inc. | 0.00% | Add +131.3% | 5,612 | $14K |
| Royal Bank of Canada | 0.00% | Add +80.5% | 1,711 | $4K |
| BNP Paribas Financial Markets | 0.00% | Reduce -46.7% | 634 | $2K |
| Nisa Investment Advisors, LLC | 0.00% | No change | 584 | $1K |
| Redwood Park Advisors LLC | 0.00% | No change | 500 | $1K |
| Russell Investments Group, Ltd. | 0.00% | No change | 481 | $1K |
| Federation des caisses Desjardins du Quebec | 0.00% | No change | 400 | $964 |
| EverSource Wealth Advisors, LLC | 0.00% | No change | 373 | $899 |
| Optima Capital LLC | 0.00% | New | 278 | $670 |
| SBI Securities Co., Ltd. | 0.00% | No change | 74 | $178 |
"% of holder's portfolio" is ACRV's weight in each manager's 13F, not the share of Acrivon Therapeutics Inc. the manager owns.